These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20110811)

  • 1. Membranous glomerulopathy: the evolving story.
    Ronco P; Debiec H
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):254-9. PubMed ID: 20110811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathogenesis of membranous glomerulonephritis.
    Ronco P; Debiec H
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):258-63. PubMed ID: 16609292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in membranous nephropathy: success stories of a long journey.
    Ronco P; Debiec H
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):460-6. PubMed ID: 21388432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of membranous nephropathy: evolution and revolution.
    Glassock RJ
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Wang C; Lu H; Yang C; Luo Y
    Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extra-membranous glomerulonephritis: from the experimental model to the human pathology of new-born and adult].
    Ronco P
    Bull Mem Acad R Med Belg; 2008; 163(3-4):179-86; discussion 186-8. PubMed ID: 19025206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
    Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy: the start of a paradigm shift.
    Herrmann SM; Sethi S; Fervenza FC
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):203-10. PubMed ID: 22240444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.
    Ronco P; Debiec H
    Lancet; 2015 May; 385(9981):1983-92. PubMed ID: 26090644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of membranous nephropathy: update.
    Kwatra IS; Prasher PK
    J Assoc Physicians India; 2013 Nov; 61(11):807-10. PubMed ID: 24974493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous nephropathy and malignancy.
    Beck LH
    Semin Nephrol; 2010 Nov; 30(6):635-44. PubMed ID: 21146128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.
    Debiec H; Nauta J; Coulet F; van der Burg M; Guigonis V; Schurmans T; de Heer E; Soubrier F; Janssen F; Ronco P
    Lancet; 2004 Oct 2-8; 364(9441):1252-9. PubMed ID: 15464186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2005 May; 16(5):1205-13. PubMed ID: 15800120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of immune complexes in membranous nephropathy.
    Xu J; Hu H; Sun Y; Zhao Z; Zhang D; Yang L; Lu Q
    Front Immunol; 2024; 15():1441017. PubMed ID: 39185424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.